SCIENION

SCIENION is a biotechnology startup founded in 2000, based in Germany. It is a global leader in precision dispensing, merging molecular biology with industrial automation. The company specializes in manufacturing robust, high-performance dispensing automation for precise deposition of biological content in ultra-low volumes, including oligonucleotides, proteins, antibodies, and glycans. Its non-contact technology, coupled with flexible software, is utilized from early R&D to mass production, enabling easy scale-up. SCIENION's portfolio also includes readers optimized for quantitative array reading, designed to surpass existing commercial readers. Through its subsidiary Cellenion, the company has patented a breakthrough technology called cellenONE, enabling high-throughput isolation and dispensing of single cells onto various substrates. In addition to its innovative technologies, SCIENION offers assay development and contract manufacturing services, covering the entire manufacturing process. The company's expansion was supported by a €4.50M Venture Round investment by IBB Invest, NRW BANK, Peppermint Group, and S-Venture Capital Dortmund in July 18, 2006.